Immunovant Stock Market Value
| IMVT Stock | USD 26.89 0.02 0.07% |
| Symbol | Immunovant |
Immunovant Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunovant. If investors know Immunovant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunovant listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.21) | Return On Assets (0.55) | Return On Equity (0.92) |
The market value of Immunovant is measured differently than its book value, which is the value of Immunovant that is recorded on the company's balance sheet. Investors also form their own opinion of Immunovant's value that differs from its market value or its book value, called intrinsic value, which is Immunovant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunovant's market value can be influenced by many factors that don't directly affect Immunovant's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunovant's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunovant is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunovant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunovant 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunovant's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunovant.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Immunovant on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Immunovant or generate 0.0% return on investment in Immunovant over 30 days. Immunovant is related to or competes with Arbutus Biopharma, Arcutis Biotherapeutics, Legend Biotech, Protagonist Therapeutics, Akero Therapeutics, Madrigal Pharmaceuticals, and Apellis Pharmaceuticals. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoim... More
Immunovant Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunovant's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunovant upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 17.16 | |||
| Value At Risk | (5.06) | |||
| Potential Upside | 3.76 |
Immunovant Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunovant's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunovant's standard deviation. In reality, there are many statistical measures that can use Immunovant historical prices to predict the future Immunovant's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.64) | |||
| Treynor Ratio | (0.18) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunovant's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunovant Backtested Returns
Immunovant holds Efficiency (Sharpe) Ratio of -0.074, which attests that the entity had a -0.074% return per unit of risk over the last 3 months. Immunovant exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunovant's Standard Deviation of 2.75, market risk adjusted performance of (0.17), and Risk Adjusted Performance of (0.05) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.17, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immunovant will likely underperform. At this point, Immunovant has a negative expected return of -0.21%. Please make sure to check out Immunovant's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Immunovant performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Immunovant has insignificant reverse predictability. Overlapping area represents the amount of predictability between Immunovant time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunovant price movement. The serial correlation of -0.19 indicates that over 19.0% of current Immunovant price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | -0.87 | |
| Residual Average | 0.0 | |
| Price Variance | 2.9 |
Immunovant lagged returns against current returns
Autocorrelation, which is Immunovant stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Immunovant's stock expected returns. We can calculate the autocorrelation of Immunovant returns to help us make a trade decision. For example, suppose you find that Immunovant has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Immunovant regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Immunovant stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Immunovant stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Immunovant stock over time.
Current vs Lagged Prices |
| Timeline |
Immunovant Lagged Returns
When evaluating Immunovant's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Immunovant stock have on its future price. Immunovant autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Immunovant autocorrelation shows the relationship between Immunovant stock current value and its past values and can show if there is a momentum factor associated with investing in Immunovant.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Immunovant Stock Analysis
When running Immunovant's price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.